Mass Spectrometry-Based Study of the Plasma Proteome in a Mouse Intestinal Tumor Model
- 27 June 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 5 (8) , 1866-1878
- https://doi.org/10.1021/pr060120r
Abstract
Early detection of cancer can greatly improve prognosis. Identification of proteins or peptides in the circulation, at different stages of cancer, would greatly enhance treatment decisions. Mass spectrometry (MS) is emerging as a powerful tool to identify proteins from complex mixtures such as plasma that may help identify novel sets of markers that may be associated with the presence of tumors. To examine this feature we have used a genetically modified mouse model, ApcMin, which develops intestinal tumors with 100% penetrance. Utilizing liquid chromatography-tandem mass spectrometry (LC−MS/MS), we identified total plasma proteome (TPP) and plasma glycoproteome (PGP) profiles in tumor-bearing mice. Principal component analysis (PCA) and agglomerative hierarchial clustering analysis revealed that these protein profiles can be used to distinguish between tumor-bearing ApcMin and wild-type control mice. Leave-one-out cross-validation analysis established that global TPP and global PGP profiles can be used to correctly predict tumor-bearing animals in 17/19 (89%) and 19/19 (100%) of cases, respectively. Furthermore, leave-one-out cross-validation analysis confirmed that the significant differentially expressed proteins from both the TPP and the PGP were able to correctly predict tumor-bearing animals in 19/19 (100%) of cases. A subset of these proteins was independently validated by antibody microarrays using detection by two color rolling circle amplification (TC−RCA). Analysis of the significant differentially expressed proteins indicated that some might derive from the stroma or the host response. These studies suggest that mass spectrometry-based approaches to examine the plasma proteome may prove to be a valuable method for determining the presence of intestinal tumors. Keywords: colon cancer • mouse • plasma biomarker • proteomics • mass spectrometryKeywords
This publication has 44 references indexed in Scilit:
- A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer1 1Investigators of the Great Lakes-New England Clinical and Epidemiology Center of the Early Detection Research Network are Dean Brenner, Daniel Normalle, and Kim Turgeon (University of Michigan), Sapna Syngal (Dana Farber Cancer Institute), Robert S. Bresalier (University of Texas M.D. Anderson Cancer Center), John Barron (Dartmouth/Hitchcock Medical Center), and Norman Marcon (University of Toronto).Gastroenterology, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002
- Interactive Exploration of Microarray Gene Expression Patterns in a Reduced Dimensional SpaceGenome Research, 2002
- Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progressionMolecular Pathology, 2000
- Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasionInternational Journal of Cancer, 1994
- Enhanced Degradation of the Ferritin Repressor Protein During Induction of Ferritin Messenger RNA TranslationScience, 1992
- Serum Amyloid P‐Component Levels in Patients with MalignancyScandinavian Journal of Immunology, 1986